This inventor holds 1 USPTO granted patent. Top assignee: N.v. Innogenetics S.a.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: **Rudolph Lucas: Innovator of TNF-alpha Muteins**
Introduction
Rudolph Lucas, a distinguished inventor based in Brussels, Belgium, has made significant contributions to the field of biotechnology. With one notable patent to his name, he is recognized for his innovative work in the preparation of TNF-alpha muteins, which hold potential implications for medical research and therapeutic applications.
Latest Patents
Lucas's premier patent focuses on "TNF-alpha muteins and a process for preparing them." This innovative approach seeks to harness the biological activity of TNF-alpha, a cytokine involved in systemic inflammation, which can be critical in understanding and treating various diseases.
Career Highlights
He is currently employed at N.V. Innogenetics S.A., a company known for its advancements in the life sciences sector. Lucas's expertise and dedication to innovation have helped propel the company's research initiatives forward.
Collaborations
Throughout his career, Rudolph has collaborated with notable colleagues such as Patrick De Baetselier and Lucia Fransen. Their combined efforts within Innogenetics demonstrate the importance of teamwork in advancing scientific research and achieving groundbreaking results.
Conclusion
Rudolph Lucas's contributions to biotechnology, particularly through his patent on TNF-alpha muteins, highlight his role as a significant innovator in the field. His work at Innogenetics and collaboration with esteemed peers underscore the collaborative nature of scientific advancements, paving the way for future research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile